×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AKYA – akoya biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AKYA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/10
08:20 am
akya
Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions [Yahoo! Finance]
Medium
Report
Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions [Yahoo! Finance]
12/10
08:15 am
akya
Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions
Low
Report
Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions
12/9
08:15 am
akya
Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone [Yahoo! Finance]
Medium
Report
Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone [Yahoo! Finance]
12/9
08:00 am
akya
Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone
Medium
Report
Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone
12/2
10:19 am
akya
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend [Globe and Mail, The (Toronto, Canada)]
Low
Report
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend [Globe and Mail, The (Toronto, Canada)]
11/19
12:22 pm
akya
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $3.00 price target on the stock, down previously from $4.00.
Low
Report
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $3.00 price target on the stock, down previously from $4.00.
11/17
08:19 am
akya
Time To Worry? Analysts Just Downgraded Their Akoya Biosciences, Inc. (NASDAQ:AKYA) Outlook [Yahoo! Finance]
High
Report
Time To Worry? Analysts Just Downgraded Their Akoya Biosciences, Inc. (NASDAQ:AKYA) Outlook [Yahoo! Finance]
11/16
08:36 am
akya
Akoya Biosciences Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
High
Report
Akoya Biosciences Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/13
05:18 pm
akya
Form 8-K Akoya Biosciences, Inc. For: Dec 11
Medium
Report
Form 8-K Akoya Biosciences, Inc. For: Dec 11
11/21
05:22 pm
akya
Form 4 Akoya Biosciences, Inc. For: Nov 19 Filed by: Kamocsay Jennifer
Low
Report
Form 4 Akoya Biosciences, Inc. For: Nov 19 Filed by: Kamocsay Jennifer
11/21
05:21 pm
akya
Form 4 Akoya Biosciences, Inc. For: Nov 19 Filed by: Ek John Frederick
Low
Report
Form 4 Akoya Biosciences, Inc. For: Nov 19 Filed by: Ek John Frederick
11/21
05:20 pm
akya
Form 4 Akoya Biosciences, Inc. For: Nov 19 Filed by: Ramachandran Niro Ph.D
Low
Report
Form 4 Akoya Biosciences, Inc. For: Nov 19 Filed by: Ramachandran Niro Ph.D
11/21
05:20 pm
akya
Form 4 Akoya Biosciences, Inc. For: Nov 19 Filed by: BAMFORD PASCAL
Low
Report
Form 4 Akoya Biosciences, Inc. For: Nov 19 Filed by: BAMFORD PASCAL
11/21
05:19 pm
akya
Form 4 Akoya Biosciences, Inc. For: Nov 19 Filed by: McKelligon Brian
Low
Report
Form 4 Akoya Biosciences, Inc. For: Nov 19 Filed by: McKelligon Brian
11/14
05:02 pm
akya
Form 10-Q Akoya Biosciences, Inc. For: Sep 30
Low
Report
Form 10-Q Akoya Biosciences, Inc. For: Sep 30
11/14
04:10 pm
akya
Form 8-K Akoya Biosciences, Inc. For: Nov 14
High
Report
Form 8-K Akoya Biosciences, Inc. For: Nov 14
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: